| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050583493 |
| P356 | DOI | 10.1186/SCRT446 |
| P932 | PMC publication ID | 4055092 |
| P698 | PubMed publication ID | 24759263 |
| P5875 | ResearchGate publication ID | 261837844 |
| P50 | author | Rongrong Hua | Q54111901 |
| Yihua An | Q81226847 | ||
| P2093 | author name string | Jing Shi | |
| Xiaodong Wang | |||
| Guanghui Dai | |||
| Zan Zhang | |||
| Pei Zheng | |||
| Hongbin Cheng | |||
| Xuebin Liu | |||
| Xinxin Niu | |||
| P2860 | cites work | Inflammation, stress, and diabetes | Q24523336 |
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury | Q24646208 | ||
| Use and abuse of HOMA modeling | Q28263292 | ||
| Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus | Q28297489 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Interleukin-1-receptor antagonist in type 2 diabetes mellitus | Q29619001 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| Normalization of obesity-associated insulin resistance through immunotherapy | Q34994222 | ||
| Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts | Q35664090 | ||
| An immune origin of type 2 diabetes? | Q36112058 | ||
| Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species | Q37038026 | ||
| Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. | Q37257183 | ||
| Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. | Q37649260 | ||
| Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
| Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study | Q40603438 | ||
| Human umbilical cord blood-derived mesenchymal stem cells improve neurological abnormalities of Niemann-Pick type C mouse by modulation of neuroinflammatory condition | Q43177262 | ||
| Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus | Q43290819 | ||
| Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial | Q43869392 | ||
| Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). | Q43869405 | ||
| Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets? | Q46774741 | ||
| Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies | Q49015799 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. | Q51348903 | ||
| Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction | Q80319873 | ||
| T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance | Q81108550 | ||
| Diagnosis and classification of diabetes mellitus | Q82064791 | ||
| Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus | Q84311000 | ||
| Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia | Q85431592 | ||
| P433 | issue | 2 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 57 | |
| P577 | publication date | 2014-04-23 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus | |
| P478 | volume | 5 |
| Q46571663 | A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy. |
| Q92910500 | Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes |
| Q35778610 | Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy |
| Q47415977 | Can Youthful Mesenchymal Stem Cells from Wharton's Jelly Bring a Breath of Fresh Air for COPD? |
| Q26748676 | Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis |
| Q92705272 | Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice |
| Q42362311 | Exendin-4 enhances the differentiation of Wharton's jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers |
| Q92759389 | Feature Article: Transplantation of neuregulin 4-overexpressing adipose-derived mesenchymal stem cells ameliorates insulin resistance by attenuating hepatic steatosis |
| Q38408964 | Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting |
| Q47141086 | Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats |
| Q53292370 | Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. |
| Q89833740 | Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications |
| Q53063065 | Integrated culture platform based on a human platelet lysate supplement for the isolation and scalable manufacturing of umbilical cord matrix-derived mesenchymal stem/stromal cells. |
| Q91612536 | Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model |
| Q37204124 | Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes |
| Q93165383 | Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice |
| Q28354224 | Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy |
| Q64881336 | Mesenchymal Stem Cells-Potential Applications in Kidney Diseases. |
| Q33691629 | Mesenchymal stem cell therapy in type 2 diabetes mellitus |
| Q46404769 | Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis |
| Q92521567 | Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation |
| Q26799107 | Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies |
| Q38694953 | Mesenchymal stromal cells ameliorate oxidative stress-induced islet endothelium apoptosis and functional impairment via Wnt4-β-catenin signaling. |
| Q59790769 | Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats |
| Q26741792 | Stem Cells Applications in Regenerative Medicine and Disease Therapeutics |
| Q64948643 | Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. |
| Q38262671 | Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications |
| Q26744774 | Stem cells to replace or regenerate the diabetic pancreas: Huge potential & existing hurdles |
| Q89496687 | The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis |
| Q89737509 | Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges |
| Q39455373 | Therapeutic potential of mesenchymal stem cells for diabetes |
| Q98564418 | Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells |
| Q26798214 | Umbilical Cord Tissue-Derived Cells as Therapeutic Agents |
| Q41101194 | Villous Chorion: A Potential Source for Pluripotent-like Stromal Cells |
| Q50554094 | Vitamin C stimulates human gingival stem cell proliferation and expression of pluripotent markers. |
| Q35226718 | Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance |
| Q110659645 | hMSCs Migrate under the Chemotaxis of CXCL-13 and Enhance Islet B Cell Activity through p-AKT Signaling Pathway in High-Glucose Environment |
Search more.